Abivax announced the appointment of three key executives to its leadership team to support potential commercialization and ...

Swiss pharma major Novartis (SIX: NOVN) is committing more than 3.3 billion yuan ($480 million) to expand its footprint in ...

Disruption in the Gulf has tightened oil flows through the Strait of Hormuz, a route that typically carries about a quarter ...

US biotech ReAlta Life Sciences has appointed Howard Berman as chairman and chief executive officer and Kia Motesharei as ...

US biotech Gilead Sciences and Belgium’s Galapagos have announced the closing of the global research and development ...

A private US biotechnology company, Endevica Bio develops peptide therapeutics and peptidomimetics that target GPCR biology, ...

Singapore-based biotech Prestige Biopharma has reported positive Phase III results for its Avastin (bevacizumab) biosimilar ...

US biotech Ocugen today released full Phase II ArMaDa data for OCU410, its investigational gene therapy for geographic ...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Keytruda (pembrolizumab), within its marketing authorization, for patients identified for surgery with ...

UK-based Immutrin, a biotech developing next generation antibody therapy to reverse amyloidosis, has successfully raised £65 ...

Karyopharm Therapeutics today reported top-line results from its Phase III SENTRY Trial in myelofibrosis that met the first ...

China’s approval of Sciwind Biosciences’ ecnoglutide injection as the fifth GLP-1 obesity therapy signals intensifying ...